QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Day 2 at ISPOR
As Day 2 at ISPOR annual comes to close, the Quantify team is feeling thankful for another day connecting with industry colleagues, partners, and some great programming. If we haven’t see you yet, it’s not too late – drop by booth 337 tomorrow morning!
First day at ISPOR!
The Quantify team had a great first day at ISPOR and we’re looking forward to what tomorrow has in store. Drop by booth 337 to say hello!
Also – don’t miss our poster on the Economic Burden of Prescription Opioid Abuse in the United States on Tuesday afternoon at 4 pm.
Alzheimer’s & Dementia publications
Quantify Research is recognized as one of the 10 most cited publications last year in the renowned journal Alzheimer’s & Dementia!
Our work with Project Alzheimer Value Europe titled “Global estimates on the number of persons across the Alzheimer’s disease continuum” is available open-access.
Head over to our website to read more!
Last month, the findings from Quantify´s large RWE study using Danish RWD was presented at WCO- IOF-ESCEO
“This cohort patient study provides an invaluable blueprint to inform future treatment decision-making and support optimal use of romosozumab in clinical practice, both in Denmark and across Europe,” said Emmanuel Caeymaex, Executive Vice President, Immunology and U.S. Solutions at UCB. “The study findings enable us to understand the use of romosozumab as a treatment option in the real world and demonstrate its potential in […]